Matricelf Ltd (TLV:MTLF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 498.10
-4.10 (-0.82%)
Mar 9, 2026, 5:24 PM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 146.87 million as of March 9, 2026. Its market cap has increased by 150.61% in one year.
Market Cap
146.87M
Enterprise Value
142.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
498.10
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 146.87M, an increase of 136.89%. That is a compound annual growth rate of 20.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 146.87M | -3.34% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 277.04M |
| Clal Biotechnology Industries | 46.43M |
| Bonus BioGroup | 512.72M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 31.31M |
| Evogene | 21.42M |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 19.70M |